Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis

BACKGROUND: With the emergence of disease-modifying Alzheimer’s treatments, timely detection of early-stage disease is more important than ever, as the treatment will not be indicated for later stages. Contemporary population-level data for detection rates of mild cognitive impairment (MCI), the sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattke, Soeren, Jun, Hankyung, Chen, Emily, Liu, Ying, Becker, Andrew, Wallick, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362635/
https://www.ncbi.nlm.nih.gov/pubmed/37481563
http://dx.doi.org/10.1186/s13195-023-01272-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362635/
https://www.ncbi.nlm.nih.gov/pubmed/37481563
http://dx.doi.org/10.1186/s13195-023-01272-z

Ejemplares similares